Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.

The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7?

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.

The team explores how the industry may be missing out on insights from HCPs and hears from Robert Tegge, Associate Principal, ZS, who shares valuable insights on congresses.

Dr Harmony Garges, Chief Medical Officer, ViiV Healthcare, discusses how best to serve patients of all ages living with HIV around the world.

Danie du Plessis, Executive Vice President, Pharmaceutical Operations, Kyowa Kirin, talks about patient partnerships will need to evolve with a changing world, the future of medical affairs and more.

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, unpicks the current small molecule funding landscape, how to improve incentives to invest in rare diseases and more.

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Isabel is joined by Tim Uden, Creative Director, EMJ to discuss the new frontier of medical education tools and skills – interactive content.

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.

Mercedes Diz, Chief Marketing Officer, Almirall, talks about pushing your limits to achieve your goals and how to be more patient centric.

This special episode features three of last year’s guests, who share their predictions for the pharmaceutical industry’s year ahead.

Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals. 

Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.

In this episode of GOLD Podcast, Isabel brings you a curated selection of insights from the pharma leaders we have heard from so far. Listen now!

Tune in for a sneak peek of GOLD’s latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.

Listen to Isabel and Jade discussing how oncology teams can best increase the pace of innovation with Jaime Manzanera Gómez, EMEA Brand Director, Oncology, Eisai.

Listen to Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis discussing diversity, equity and inclusion.

Discover why healthcare professionals are losing trust in pharma marketing. Listen the episode as the GOLD team delves into the industry’s challenges.

The evolution of customer engagement in pharmaceutical industry according to Rick Hollis, Director of Business Excellence, Ipsen. Listen now!

In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!

Discover the reality behind the rare disease research with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer

In this episode, Nate Cope, Chief Operating Officer, Otsuka Europe, details how companies can drive innovation by being a great place to work.

Parveen Jayia, Therapy Area Head, Breast and Gynaecological Cancers, AstraZeneca, talks to GOLD about the role digital health can play in the future of the industry.

Join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.

As Season 5 of the GOLD podcast approaches its end, join Isabel and Jade as they share some of the most memorable moments from the last couple of months.

Uncover the latest customer expectations of medical affairs in this episode of the GOLD podcast, which sees the team speak with not one but two medical affairs leaders from top healthcare consultancy firm, ZS.

In this episode, Jade picks the brains of Anita Ralli, Director, Government Affairs, Inclusion and Diversity, Employee Resource Group Lead, Gilead Sciences UK to find out how companies can attract diverse talent to their workforce.

In this week’s episode, Isabel and Jade share some snippets from the interview with GOLD’s next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring.

Navigate the evolving landscape of cell therapy with hosts Isabel and Jade as they present an insightful discussion with Warner Biddle, former Senior Vice President and Global Head of Commercial, Kite, a Gilead Company.

This week, the GOLD team looks into how the industry can support patients and staff in the LGBTQ+ community.

In this episode, Isabel discusses with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca about his passion for working in oncology.

Tune in to the next episode of the GOLD podcast to hear the team’s latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry’s evolving commercial model.

The GOLD team are delighted to announce that Season 5 of the GOLD Podcast is going to be returning on 6 June!

To mark the final episode of Season 4, Isabel and Jade reminisce about their favourite moments from the series and give an exclusive teaser for the next issue of GOLD magazine.

The GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and varied experience within the pharmaceutical industry.

In this episode, Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, discusses creating modular content and leveraging AI within the pharma industry.

This week, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in pharma.

This week, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation.

The GOLD team brings you a special International Women’s Day (IWD) podcast to celebrate the pursuit of gender parity.

In this episode, Isabel chats with Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS.

Isabel chats to Darshan Kulkarni, regulatory and compliance attorney for the Life Sciences, about key marketing and medical affairs trends.

Helena and Isabel share exclusive clips from the conversation with GOLD’s latest Catalyst interviewee: AstraZeneca’s Mina Makar.

Helena and Isabel kick off Season 4 with Janssen’s Kavita Panke, talking all things neuroscience, high performing teams and more!

Join Helena and Isabel in ringing in the 2023 with a special predictions episode. What’s in store for pharma this year?

Helena and Isabel are joined by six guests to round off 2022 and Season 3 with a look back at the key highlights of the past 12 months.

In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.

Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GS

Helena and Isabel share a very special episode to mark World AIDS Day, featuring Dr Nneka Nwokolo, Global Head of Patient Affairs at ViiV.

Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax, discusses her passion for engaging the world in the wonder of science.

In this episode, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson.

Helena and Jade introduce a discussion on the future of digital therapeutics with Eugene Borukhovich, Co-Founder and COO, YourCoach.Health.

Listen to the GOLD team: Helena, Isabel and Jade will discuss key articles, themes and insights from the latest issue of GOLD.

In this episode, Helena and Isabel are joined by Patrick Short, CEO, Sano Genetics, to discuss the challenges and opportunities facing genetic medicine.

Helena and Isabel speak to GOLD catalyst interviewee Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology.

Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.

This week, Helena and Isabel are honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines.

Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.

In this episode, Helena hosts a medical affairs discussion with Novartis UK’s Samin Saeed about leadership, company culture, soft skills development and much more.

Marc and Helena are joined by Pav Rishiraj, Director and Head of Pharmacovigilance, Ipsen, to shed light on this often-overlooked field.

An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.

As Helena and Marc wrap up this season, they’re joined by Mike Watson, CEO of Mevox, to discuss past present and future of vaccines.

In this episode, Helena and Marc are joined by Claire Gillis, CEO, VMLY&R Health, to discuss the health and pharma highlights from the recent Cannes Lions.

Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.

In this episode, Helena and Marc are joined by Claus Zieler, President of Established Markets, Astellas, to discuss leadership and crisis management.

Marc, Helena and the team are joined by Luca Dezzani, Vice President, Oncology Medical Affairs, J&J, to talk all things medical affairs. Listen now!

In this Men’s Health Week special, the GOLD team is joined by Peter Baker, Director, Global Action on Men’s Health and Chumi Khurana, Global

This week, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso, to talk about immunometabolism and pharma predictions.

In this episode, GOLD is joined by Natalie Yeadon, Co-founder and CEO of Impetus Digital to talk all things gamification in pharma.

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with an interview with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD.

In this episode, GOLD is joined by two international experts in market access, talking about pricing, reimbursement and more in South Africa and Europe.

In this bonus episode, Helena offers her reflections on the Next Pharma Summit, and Isabel catches up with the event founder Dario Safaric.

In this episode, Helena and Marc are joined by Amgen’s Emma Booth to discuss all things R&D, plus medical affairs communication and more.

For this episode, the team is joined by Wendy Bartie, BMS, and Courtney Billington, Janssen Neuroscience, to talk all things mental health: awareness, access and influence in pharma.

In this episode, Marc and Helena are joined by Leo Pharma’s Klaus League to discuss social sustainability, patient advocacy and policy campaigning.

Marc and Helena are joined by Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca, and many more guests, talking medical affairs, RWE and TikTok marketing.

In this episode, Marc and Helena talk about digital access with Alira Health’s Aaron Grandy and about haemophilia with patient advocate Laurence Woollard.

In this episode, at the season’s half way point, Marc, Helena and Isabel look back at our 2022 predictions for pharma industry – were our guests right?

Marc presents exclusive snippets from an interview with our next catalist, Davidek Herron, Global Head of Digital, Roche.

Magnus Björsne, CEO, AstraZeneca BioVentureHub, discusses the impact of the pandemic on innovation, collaboration and creativity.

In this episode, Marc and Helena talk China with Novartis’ Isabel Afonso and drug development with Farid Khan, CEO of PharmaKure. Listen now!

Bonus episode this week for GOLD podcast, featuring a full feature-length interview with Claire Skentelbery, Director General, EuropaBio. Stream now!

In this episode, Marc and Helena have a chat about biotech with special guest Claire Skentelbery, Director General of EuropaBio.

In this episode, Marc and Helena will chat with GP Nigel Guest about his thoughts about preventative medicines and his insights for pharma sales teams.

In this special bumper episode, GOLD celebrates International Women’s Day by speaking to Nikki Jones (HBA) and Aliya Omer (Kite Pharma) about the role of women in pharma industry.

New podcast episode about digital health apps and the metaverse. Guests Liz Ashall-Payne (ORCHA) and Dario Safaric (NEXT Pharma). Listen now!

Marc and Helena chat with Wayne Best, Chief Creative Officer, VMLY&R, about his ‘I Will Always Be Me’ project for patients with motor neurone disease. Listen now!

A chat with Judy Stewart (GSK) and Vincent Steine in the first episode of a new season of GOLD podcasts. Tune in to find out more about vaccines, pharma and blockchain.

Marc and Helena review the last year and reminisce about the podcast’s ‘GOLD Medal Moments’ from the past 12 months. Listen now!

Marc and Helena introduce Margo Warren from the Access to Medicine Foundation to discuss health equality and vaccine distribution.

Join Marc and Helena in kicking off the new year with an episode predicting what 2022 has in store for pharma. Listen now!

To round off the year, three GOLD Podcast guests return to review 2021 in the pharmaceutical industry. Listen now!

Catherine Owen, Head of Major Markets at Bristol Myers Squibb, discusses upcoming changes to pharma’s data policies.

Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, discusses her lifelong passion for diversity.

Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology speaks about her pathway into men’s health and more.

Dr Richard Kaszynski, Chief Medical Officer, AiPharma, discusses the emerging role of antivirals in healthcare.

Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses with GOLD team her passion for digital health tools.

Dr Emma Roffe, Takeda UK, and Eric Low, Myeloma UK, talk about the challenge of combination treatments.

Massimiliano Siciliano, Digital Solution Director Europe, Novartis, talks about the potential of digital solutions for pharma stakeholders.

Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen, discusses drug pricing.

Julie Ross, President, Advanced Clinical, talks about gender parity in the workplace in aid of International Equal Pay Day.

Carol Lynch, Chief Business Officer, Sandoz, talks about how to increase the number of women in leadership positions in pharma and more.

Keren Leshem, Chief Executive Officer, OCON Healthcare, discusses how she transformed the women’s health company’s business strategy.

Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, discusses the MA impact on improving patient outcomes.

Dr Jerome Kim, Director General, International Vaccine Institute, discusses pharma’s role in addressing vaccine hesitancy and refusal.

Dirk Kosche, President, Established Markets, Astellas Pharma Europe, discusses turning innovation into value for patients.

Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy, discusses clinical trials.

Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.

Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, talks about leadership and the evolving medical sales representative role.

Denise Dewar, Digital Hub Director, Europe, Japan and Canada, GSK, discusses digital transformation and swapping whisky for pharma.

Ana Rita Ferreira, Region Europe Medical Director, Novartis, discusses cancer care, women in STEM and misinformation.

Lorena Kuri, Director of Clinical Trial Diversity Strategy, BMS, discusses how to address underrepresentation in clinical trials.

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

Sir Clive Woodward, Former England Rugby Coach, discusses the importance of teams having aligned values and the rules of teamship.

Sir Clive Woodward, Former England Rugby Coach, discusses the concept of ‘Lombardi Time’ and how winning teams should embrace it.

Florent Edouard, ‎Senior Vice President, Global Head of Commercial Excellence, Grünenthal Group, talks about AI in digital transformation.

Dr Emily Pegg, Head of Medical Affairs UK, Takeda Oncology, discusses how pharma’s relationship with HCPs is evolving.

Timothy White, Vice President and Head of Global Digital Commercial, Teva Pharmaceuticals, discusses the subject of digital transformation.